MSP: Methylation-specific PCR; MSRE: Methylation-sensitive restriction endonucleases; QMSP: Quantitative, methylation-specific PCR; X: Methylation associated with prognosis. Mohammad Obaidul Hoque, ...

Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system. Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ...

Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary Detectability by Gleason grade ...

Findings show that Telomir-1 restores the body’s natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A – genes that help block invasion, limit metastasis, and ...

Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks. This process is mediated by molecules ...

Researchers have developed a blood test that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma (CRPC-adeno). Like a ...

New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been discovered. New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been discovered ...

Figure 5: Analysis of glucose-dependent PDX1 activity and metabolic markers in prostate cancer cells. The study was led by first author Tayo A. Adeyika and corresponding author Bernard Kwabi-Addo from ...

Many cancers, including pancreatic, ovarian, esophageal, and certain liver cancers, are often diagnosed at advanced stages ...

New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been discovered by scientists at the Garvan Institute of Medical Research. The biomarkers can be used in combination ...